Ryan Specialty Holdings, Inc. RYAN
Composite 47/100; the shares have moved about 46% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 35/100 — a moderate mark against it.
Growth ranks 62/100 — a moderate point in its favour. Quality ranks 53/100 — a slight point in its favour.
Valuation ranks 35/100 — a moderate mark against it. Balance-sheet strength ranks 40/100 — a slight mark against it. Momentum ranks 46/100 — a slight mark against it.
What the company does Ryan Specialty Holdings, Inc. (RYAN) is a wholesale specialty insurance broker and program administrator offering underwriting, distribution, and risk management services to U.S. and international clients across commercial, industrial, and government sectors.
Key financials RYAN reports strong profitability with ROE 22.8%, ROA 3.6%, and ROCE 9.2%. Gross, operating, and net margins stand at 41.8%, 17.4%, and 3.5%, respectively. Revenue grew 15.8% and EPS surged 110.1%, though leverage is high (Debt/Equity 3.07) and interest coverage is 2.32.
Stock health Momentum is mixed: up 25.56% over 3 months but down -25.61% over 12 months, with RSI at 61.00. The Sideravia Score of 51.5 reflects average quality, weak momentum, and fair valuation.
Price vs fair value RYAN trades at a PREMIUM of 21.70% to our fair-value estimate of 34.52 and a discount of 4.05% to the analyst 12-month target of 45.88. - Q2 CY2026 results beat estimates, with revenue and earnings surprises (Zacks, StockStory). - Stock surged 16.1% on earnings beat (StockStory). - Bullish stance from Vulcan Value Partners cited by Insider Monkey. - Forward P/E of 20.16 vs current P/E of 50.81 supports valuation gap.
Looking forward Forward P/E of 20.16 and PEG of 0.13 suggest potential re-rating if growth sustains, though high leverage and weak 12-month momentum warrant caution.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.